The Infertility Devices Market, estimated at USD 11,969.3 Mn in 2025, is expected to exhibit a CAGR of 8.7% and reach USD 21,462.3 Mn by 2032.
The industry is witnessing significant growth driven by rising demand for advanced, reliable, and cost-effective medical devices across diagnostic, therapeutic, and monitoring applications. Rapid advancements in device design, digital health integration, and adoption of minimally invasive technologies are reshaping the competitive landscape. Furthermore, supportive regulatory frameworks, increasing healthcare investments, and the growing focus on patient-centric care are expected to create new growth avenues for market players.
The key market players in the market are focusing on the adoption of organic growth strategies, such as product expansion of facilities center. For instance, in August 2025, INVO Bioscience, Inc., a commercial-stage fertility company, announced that Advanced Reproductive Centre, Hospital Canselor Tuanku Muhriz (HCTM), formally known as Hospital Universiti Kebangsaan Malaysia (HUKM), based in Kuala Lumpur, Malaysia. The move follows the successful completion of the first IVC case in the country recently with data presented at the Obstetrical and Gynecological Society of Malaysia ("OGSM") where it was awarded a prize as a new and innovative fertility treatment.
Global Infertility Devices Market– Impact of Coronavirus (COVID-19) Pandemic
The World Health Organization (WHO) designated the illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan (province of Hubei, China) in the last months of 2025 as "coronavirus disease 2025" or COVID-19. This virus spread quickly and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.
COVID-19 affected the economy in three main ways: by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to the lockdown, several countries such as India, China, Brazil, and others faced problems with regard to the transportation of drugs from one place to another.
Global Infertility Devices Market: Key Developments
Rising product launches by the market players is expected to propel the market growth over the forecast period. For instance, in November 2025, Thermo Fisher Scientific Inc., a scientific instruments and reagents supplier, launched two new products for in-vitro fertilization (IVF) applications, the Thermo Scientific Nunc IVF ICSI and Center Well petri dishes.
Browse 38 Market Data Tables and 29 Figures spread through 170 Pages and in-depth TOC on “Global Infertility Devices Market”- Forecast to 2032, Global Infertility Devices Market, by Product Type (Equipment (Imaging Systems, Sperm Analyzer Systems, Ovum Aspiration Pumps, Micromanipulators Systems, Incubators, Gas Analyzers, Laser Systems, Cryosystems) (Accessories)) by Procedure (Assisted Reproductive Technology, Artificial Insemination, Fertility Surgery, Others) By Gender (Male, Female) by End User (Fertility Centers, Hospitals & Surgical Clinics, Cryobanks) Others by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
To know the latest trends and insights prevalent in this market, click the link below:
https://www.coherentmarketinsights.com/market-insight/infertility-devices-market-2579
Key Takeaways of the Global Infertility Devices Market:
- The global infertility devices market is expected to exhibit a CAGR of 8.7% during the forecast period. For instance in November 2025, INVO Bioscience, highlights its INVOcell’s progress From The 2025 American Society For Reproductive Medicine (ASRM) Congress & Expo.
- Among product type, equipment segment is estimated to hold a dominant position in the global infertility devices market over the forecast period
- Among region, North America is expected to be the dominant region in the global infertility devices market, owing to increasing technological advancement by key market players, to expand the product portfolio and strengthen their market presence, which is expected to drive the segment growth over the forecast period
- Key players operating in the global infertility devices market include Key companies covered as part of this study include, Thermo Fisher Scientific Inc., Vitrolife AB, , The Cooper Companies, Inc., Fujifilm Irvine Scientific, IVFTECH APS, Kitazato Corporation, MedGyn Products, Inc., Rocket Medical plc, SOMATEX Medical Technologies GmbH, Cook Group Incorporated, Esco Micro Pte Ltd, Hamilton Thorne, Ltd, and Art Biotech Pvt. LTD
Contact Us